BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chaulin AM, Duplyakov DV. Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 1 (literature review). Journal of Clinical Practice. [DOI: 10.17816/clinpract34284] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zaki HA, Shaban AE, Shaban AE, Shaban EE. Interpretation of Cardiac and Non-Cardiac Causes of Elevated Troponin T Levels in Non-Acute Coronary Syndrome Patients in the Emergency Department. Cureus 2022. [DOI: 10.7759/cureus.22703] [Reference Citation Analysis]
2 Chaulin AM, Duplyakov DV. Cardiac troponins in hypertension: mechanisms of increase and diagnostic value. Arter gipertenz 2021;27:390-401. [DOI: 10.18705/1607-419x-2021-27-4-390-401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Chaulin AM, Duplyakov DV. Cardiac troponins in hypertension: mechanisms of increase and diagnostic value. Arter gipertenz 2021;27:390-401. [DOI: 10.18705/1607-419x-2021-27-3-] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chaulin AM. Hypolipidemic drugs inhibiting the proprotein convertase of subtilisin/kexin type 9 (PCSK9): monoclonal antibodies, antisense oligonucleotides, small interfering ribonucleic acids. Rev Clin Pharm Drug Ther 2021;19:37-46. [DOI: 10.17816/rcf19137-46] [Reference Citation Analysis]
5 Chaulin AM. New groups of hypolipidemic medications based on inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). Part 1. jour 2021;98:739-744. [DOI: 10.30629/0023-2149-2020-98-11-12-739-744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chaulin AM, Svechkov NA, Duplyakov DV. New groups of hypolipidemic drugs based on inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). Part 1. Science and Innovations in Medicine 2021;6:54-60. [DOI: 10.35693/2500-1388-2021-6-1-54-60] [Reference Citation Analysis]
7 Chaulin AM, Duplyakov DV. High-sensitivity cardiac troponins: circadian rhythms. Cardiovasc Ther Prev 2021;20:2639. [DOI: 10.15829/1728-8800-2021-2639] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
8 Chaulin. New Biomarkers of Cardiovascular Diseases (Literature Review). Part 1. BSP 2021;7:130-151. [DOI: 10.33619/2414-2948/63/12] [Reference Citation Analysis]
9 Chaulin AM, Duplyakov DV. Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (Literature review). Journal of Clinical Practice 2020;11:70-82. [DOI: 10.17816/clinpract48893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]